Extending  ||| S:0 E:10 ||| VBG
the  ||| S:10 E:14 ||| DT
TIME  ||| S:14 E:19 ||| NNP
concept ||| S:19 E:26 ||| NN
:  ||| S:26 E:28 ||| :
what  ||| S:28 E:33 ||| WP
have  ||| S:33 E:38 ||| VBP
we  ||| S:38 E:41 ||| PRP
learned  ||| S:41 E:49 ||| VBD
in  ||| S:49 E:52 ||| IN
the  ||| S:52 E:56 ||| DT
past  ||| S:56 E:61 ||| JJ
10  ||| S:61 E:64 ||| CD
years ||| S:64 E:69 ||| NNS
? ||| S:69 E:70 ||| .
( ||| S:70 E:71 ||| -LRB-
* ||| S:71 E:72 ||| NNP
)  ||| S:72 E:74 ||| -RRB-
The  ||| S:74 E:78 ||| DT
TIME  ||| S:78 E:83 ||| NNP
acronym  ||| S:83 E:91 ||| NNS
( ||| S:91 E:92 ||| -LRB-
tissue ||| S:92 E:98 ||| NN
,  ||| S:98 E:100 ||| ,
infection ||| S:100 E:109 ||| FW
/ ||| S:109 E:110 ||| FW
inflammation ||| S:110 E:122 ||| FW
,  ||| S:122 E:124 ||| ,
moisture  ||| S:124 E:133 ||| JJ
balance  ||| S:133 E:141 ||| NN
and  ||| S:141 E:145 ||| CC
edge  ||| S:145 E:150 ||| NN
of  ||| S:150 E:153 ||| IN
wound ||| S:153 E:158 ||| NN
)  ||| S:158 E:160 ||| -RRB-
was  ||| S:160 E:164 ||| VBD
first  ||| S:164 E:170 ||| RB
developed  ||| S:170 E:180 ||| VBN
more  ||| S:180 E:185 ||| JJR
than  ||| S:185 E:190 ||| IN
10  ||| S:190 E:193 ||| CD
years  ||| S:193 E:199 ||| NNS
ago ||| S:199 E:202 ||| RB
,  ||| S:202 E:204 ||| ,
by  ||| S:204 E:207 ||| IN
an  ||| S:207 E:210 ||| DT
international  ||| S:210 E:224 ||| JJ
group  ||| S:224 E:230 ||| NN
of  ||| S:230 E:233 ||| IN
wound  ||| S:233 E:239 ||| JJ
healing  ||| S:239 E:247 ||| NN
experts ||| S:247 E:254 ||| NNS
,  ||| S:254 E:256 ||| ,
to  ||| S:256 E:259 ||| TO
provide  ||| S:259 E:267 ||| VB
a  ||| S:267 E:269 ||| DT
framework  ||| S:269 E:279 ||| NN
for  ||| S:279 E:283 ||| IN
a  ||| S:283 E:285 ||| DT
structured  ||| S:285 E:296 ||| JJ
approach  ||| S:296 E:305 ||| NN
to  ||| S:305 E:308 ||| TO
wound  ||| S:308 E:314 ||| VB
bed  ||| S:314 E:318 ||| NN
preparation ||| S:318 E:329 ||| NN
;  ||| S:329 E:331 ||| :
a  ||| S:331 E:333 ||| DT
basis  ||| S:333 E:339 ||| NN
for  ||| S:339 E:343 ||| IN
optimising  ||| S:343 E:354 ||| VBG
the  ||| S:354 E:358 ||| DT
management  ||| S:358 E:369 ||| NN
of  ||| S:369 E:372 ||| IN
open  ||| S:372 E:377 ||| JJ
chronic  ||| S:377 E:385 ||| JJ
wounds  ||| S:385 E:392 ||| NNS
healing  ||| S:392 E:400 ||| VBG
by  ||| S:400 E:403 ||| IN
secondary  ||| S:403 E:413 ||| JJ
intention ||| S:413 E:422 ||| NN
.  ||| S:422 E:424 ||| .
However ||| S:424 E:431 ||| RB
,  ||| S:431 E:433 ||| ,
it  ||| S:433 E:436 ||| PRP
should  ||| S:436 E:443 ||| MD
be  ||| S:443 E:446 ||| VB
recognised  ||| S:446 E:457 ||| VBN
that  ||| S:457 E:462 ||| IN
the  ||| S:462 E:466 ||| DT
TIME  ||| S:466 E:471 ||| NNP
principles  ||| S:471 E:482 ||| NNS
are  ||| S:482 E:486 ||| VBP
only  ||| S:486 E:491 ||| RB
a  ||| S:491 E:493 ||| DT
part  ||| S:493 E:498 ||| NN
of  ||| S:498 E:501 ||| IN
the  ||| S:501 E:505 ||| DT
systematic  ||| S:505 E:516 ||| JJ
and  ||| S:516 E:520 ||| CC
holistic  ||| S:520 E:529 ||| JJ
evaluation  ||| S:529 E:540 ||| NN
of  ||| S:540 E:543 ||| IN
each  ||| S:543 E:548 ||| DT
patient  ||| S:548 E:556 ||| NN
at  ||| S:556 E:559 ||| IN
every  ||| S:559 E:565 ||| DT
wound  ||| S:565 E:571 ||| JJ
assessment ||| S:571 E:581 ||| NN
.  ||| S:581 E:583 ||| .
This  ||| S:583 E:588 ||| DT
review ||| S:588 E:594 ||| NN
,  ||| S:594 E:596 ||| ,
prepared  ||| S:596 E:605 ||| VBN
by  ||| S:605 E:608 ||| IN
the  ||| S:608 E:612 ||| DT
International  ||| S:612 E:626 ||| NNP
Wound  ||| S:626 E:632 ||| NNP
Infection  ||| S:632 E:642 ||| NNP
Institute ||| S:642 E:651 ||| NNP
,  ||| S:651 E:653 ||| ,
examines  ||| S:653 E:662 ||| VBZ
how  ||| S:662 E:666 ||| WRB
new  ||| S:666 E:670 ||| JJ
data  ||| S:670 E:675 ||| NNS
and  ||| S:675 E:679 ||| CC
evidence  ||| S:679 E:688 ||| NN
generated  ||| S:688 E:698 ||| VBD
in  ||| S:698 E:701 ||| IN
the  ||| S:701 E:705 ||| DT
intervening  ||| S:705 E:717 ||| JJ
decade  ||| S:717 E:724 ||| NN
affects  ||| S:724 E:732 ||| VBZ
the  ||| S:732 E:736 ||| DT
original  ||| S:736 E:745 ||| JJ
concepts  ||| S:745 E:754 ||| NNS
of  ||| S:754 E:757 ||| IN
TIME ||| S:757 E:761 ||| NNP
,  ||| S:761 E:763 ||| ,
and  ||| S:763 E:767 ||| CC
how  ||| S:767 E:771 ||| WRB
it  ||| S:771 E:774 ||| PRP
is  ||| S:774 E:777 ||| VBZ
translated  ||| S:777 E:788 ||| VBN
into  ||| S:788 E:793 ||| IN
current  ||| S:793 E:801 ||| JJ
best  ||| S:801 E:806 ||| JJS
practice ||| S:806 E:814 ||| NN
.  ||| S:814 E:816 ||| .
Four  ||| S:816 E:821 ||| CD
developments  ||| S:821 E:834 ||| NNS
stand  ||| S:834 E:840 ||| VBP
out ||| S:840 E:843 ||| RP
:  ||| S:843 E:845 ||| :
recognition  ||| S:845 E:857 ||| NN
of  ||| S:857 E:860 ||| IN
the  ||| S:860 E:864 ||| DT
importance  ||| S:864 E:875 ||| NN
of  ||| S:875 E:878 ||| IN
biofilms  ||| S:878 E:887 ||| NNS
( ||| S:887 E:888 ||| -LRB-
and  ||| S:888 E:892 ||| CC
the  ||| S:892 E:896 ||| DT
need  ||| S:896 E:901 ||| NN
for  ||| S:901 E:905 ||| IN
a  ||| S:905 E:907 ||| DT
simple  ||| S:907 E:914 ||| JJ
diagnostic ||| S:914 E:924 ||| JJ
) ||| S:924 E:925 ||| -RRB-
,  ||| S:925 E:927 ||| ,
use  ||| S:927 E:931 ||| NN
of  ||| S:931 E:934 ||| IN
negative  ||| S:934 E:943 ||| JJ
pressure  ||| S:943 E:952 ||| NN
wound  ||| S:952 E:958 ||| NN
therapy  ||| S:958 E:966 ||| NN
( ||| S:966 E:967 ||| -LRB-
NPWT ||| S:967 E:971 ||| NNP
) ||| S:971 E:972 ||| -RRB-
,  ||| S:972 E:974 ||| ,
evolution  ||| S:974 E:984 ||| NN
of  ||| S:984 E:987 ||| IN
topical  ||| S:987 E:995 ||| JJ
antiseptic  ||| S:995 E:1006 ||| JJ
therapy  ||| S:1006 E:1014 ||| NN
as  ||| S:1014 E:1017 ||| IN
dressings  ||| S:1017 E:1027 ||| NN
and  ||| S:1027 E:1031 ||| CC
for  ||| S:1031 E:1035 ||| IN
wound  ||| S:1035 E:1041 ||| JJ
lavage  ||| S:1041 E:1048 ||| NNS
( ||| S:1048 E:1049 ||| -LRB-
notably ||| S:1049 E:1056 ||| RB
,  ||| S:1056 E:1058 ||| ,
silver  ||| S:1058 E:1065 ||| NN
and  ||| S:1065 E:1069 ||| CC
polyhexamethylene  ||| S:1069 E:1087 ||| JJ
biguanide ||| S:1087 E:1096 ||| NN
)  ||| S:1096 E:1098 ||| -RRB-
and  ||| S:1098 E:1102 ||| CC
expanded  ||| S:1102 E:1111 ||| VBD
insight  ||| S:1111 E:1119 ||| VBN
of  ||| S:1119 E:1122 ||| IN
the  ||| S:1122 E:1126 ||| DT
role  ||| S:1126 E:1131 ||| NN
of  ||| S:1131 E:1134 ||| IN
molecular  ||| S:1134 E:1144 ||| JJ
biological  ||| S:1144 E:1155 ||| JJ
processes  ||| S:1155 E:1165 ||| NNS
in  ||| S:1165 E:1168 ||| IN
chronic  ||| S:1168 E:1176 ||| JJ
wounds  ||| S:1176 E:1183 ||| NNS
( ||| S:1183 E:1184 ||| -LRB-
with  ||| S:1184 E:1189 ||| IN
emerging  ||| S:1189 E:1198 ||| VBG
diagnostics  ||| S:1198 E:1210 ||| NNS
and  ||| S:1210 E:1214 ||| CC
theranostics ||| S:1214 E:1226 ||| CD
) ||| S:1226 E:1227 ||| -RRB-
.  ||| S:1227 E:1229 ||| .
Tissue ||| S:1229 E:1235 ||| NN
:  ||| S:1235 E:1237 ||| :
a  ||| S:1237 E:1239 ||| DT
major  ||| S:1239 E:1245 ||| JJ
advance  ||| S:1245 E:1253 ||| NN
has  ||| S:1253 E:1257 ||| VBZ
been  ||| S:1257 E:1262 ||| VBN
the  ||| S:1262 E:1266 ||| DT
recognition  ||| S:1266 E:1278 ||| NN
of  ||| S:1278 E:1281 ||| IN
the  ||| S:1281 E:1285 ||| DT
value  ||| S:1285 E:1291 ||| NN
of  ||| S:1291 E:1294 ||| IN
repetitive  ||| S:1294 E:1305 ||| JJ
and  ||| S:1305 E:1309 ||| CC
maintenance  ||| S:1309 E:1321 ||| NN
debridement  ||| S:1321 E:1333 ||| NNS
and  ||| S:1333 E:1337 ||| CC
wound  ||| S:1337 E:1343 ||| JJ
cleansing ||| S:1343 E:1352 ||| NN
,  ||| S:1352 E:1354 ||| ,
both  ||| S:1354 E:1359 ||| DT
in  ||| S:1359 E:1362 ||| IN
time-honoured  ||| S:1362 E:1376 ||| JJ
and  ||| S:1376 E:1380 ||| CC
novel  ||| S:1380 E:1386 ||| NN
methods  ||| S:1386 E:1394 ||| NNS
( ||| S:1394 E:1395 ||| -LRB-
notably  ||| S:1395 E:1403 ||| RB
using  ||| S:1403 E:1409 ||| VBG
NPWT  ||| S:1409 E:1414 ||| NNP
and  ||| S:1414 E:1418 ||| CC
hydrosurgery ||| S:1418 E:1430 ||| CD
) ||| S:1430 E:1431 ||| -RRB-
.  ||| S:1431 E:1433 ||| .
Infection ||| S:1433 E:1442 ||| NNP
/ ||| S:1442 E:1443 ||| NNP
inflammation ||| S:1443 E:1455 ||| NN
:  ||| S:1455 E:1457 ||| :
clinical  ||| S:1457 E:1466 ||| JJ
recognition  ||| S:1466 E:1478 ||| NN
of  ||| S:1478 E:1481 ||| IN
infection  ||| S:1481 E:1491 ||| NN
( ||| S:1491 E:1492 ||| -LRB-
and  ||| S:1492 E:1496 ||| CC
non  ||| S:1496 E:1500 ||| JJ
infective  ||| S:1500 E:1510 ||| JJ
causes  ||| S:1510 E:1517 ||| NNS
of  ||| S:1517 E:1520 ||| IN
persisting  ||| S:1520 E:1531 ||| JJ
inflammation ||| S:1531 E:1543 ||| NN
)  ||| S:1543 E:1545 ||| -RRB-
is  ||| S:1545 E:1548 ||| VBZ
critical ||| S:1548 E:1556 ||| JJ
.  ||| S:1556 E:1558 ||| .
The  ||| S:1558 E:1562 ||| DT
concept  ||| S:1562 E:1570 ||| NN
of  ||| S:1570 E:1573 ||| IN
a  ||| S:1573 E:1575 ||| DT
bacterial  ||| S:1575 E:1585 ||| JJ
continuum  ||| S:1585 E:1595 ||| NN
through  ||| S:1595 E:1603 ||| IN
contamination ||| S:1603 E:1616 ||| NN
,  ||| S:1616 E:1618 ||| ,
colonisation  ||| S:1618 E:1631 ||| NN
and  ||| S:1631 E:1635 ||| CC
infection  ||| S:1635 E:1645 ||| NN
is  ||| S:1645 E:1648 ||| VBZ
now  ||| S:1648 E:1652 ||| RB
widely  ||| S:1652 E:1659 ||| RB
accepted ||| S:1659 E:1667 ||| VBN
,  ||| S:1667 E:1669 ||| ,
together  ||| S:1669 E:1678 ||| RB
with  ||| S:1678 E:1683 ||| IN
the  ||| S:1683 E:1687 ||| DT
understanding  ||| S:1687 E:1701 ||| NN
of  ||| S:1701 E:1704 ||| IN
biofilm  ||| S:1704 E:1712 ||| JJ
presence ||| S:1712 E:1720 ||| NN
.  ||| S:1720 E:1722 ||| .
There  ||| S:1722 E:1728 ||| EX
has  ||| S:1728 E:1732 ||| VBZ
been  ||| S:1732 E:1737 ||| VBN
a  ||| S:1737 E:1739 ||| DT
return  ||| S:1739 E:1746 ||| NN
to  ||| S:1746 E:1749 ||| TO
topical  ||| S:1749 E:1757 ||| VB
antiseptics  ||| S:1757 E:1769 ||| VBN
to  ||| S:1769 E:1772 ||| TO
control  ||| S:1772 E:1780 ||| VB
bioburden  ||| S:1780 E:1790 ||| VBN
in  ||| S:1790 E:1793 ||| IN
wounds ||| S:1793 E:1799 ||| NNS
,  ||| S:1799 E:1801 ||| ,
emphasised  ||| S:1801 E:1812 ||| VBG
by  ||| S:1812 E:1815 ||| IN
the  ||| S:1815 E:1819 ||| DT
awareness  ||| S:1819 E:1829 ||| NN
of  ||| S:1829 E:1832 ||| IN
increasing  ||| S:1832 E:1843 ||| VBG
antibiotic  ||| S:1843 E:1854 ||| JJ
resistance ||| S:1854 E:1864 ||| NN
.  ||| S:1864 E:1866 ||| .
Moisture ||| S:1866 E:1874 ||| NNP
:  ||| S:1874 E:1876 ||| :
the  ||| S:1876 E:1880 ||| DT
relevance  ||| S:1880 E:1890 ||| NN
of  ||| S:1890 E:1893 ||| IN
excessive  ||| S:1893 E:1903 ||| JJ
or  ||| S:1903 E:1906 ||| CC
insufficient  ||| S:1906 E:1919 ||| JJ
wound  ||| S:1919 E:1925 ||| NN
exudate  ||| S:1925 E:1933 ||| NNS
and  ||| S:1933 E:1937 ||| CC
its  ||| S:1937 E:1941 ||| PRP$
molecular  ||| S:1941 E:1951 ||| JJ
components  ||| S:1951 E:1962 ||| NNS
has  ||| S:1962 E:1966 ||| VBZ
led  ||| S:1966 E:1970 ||| VBN
to  ||| S:1970 E:1973 ||| TO
the  ||| S:1973 E:1977 ||| DT
development  ||| S:1977 E:1989 ||| NN
and  ||| S:1989 E:1993 ||| CC
use  ||| S:1993 E:1997 ||| NN
of  ||| S:1997 E:2000 ||| IN
a  ||| S:2000 E:2002 ||| DT
wide  ||| S:2002 E:2007 ||| JJ
range  ||| S:2007 E:2013 ||| NN
of  ||| S:2013 E:2016 ||| IN
dressings  ||| S:2016 E:2026 ||| VBG
to  ||| S:2026 E:2029 ||| TO
regulate  ||| S:2029 E:2038 ||| VB
moisture  ||| S:2038 E:2047 ||| JJ
balance ||| S:2047 E:2054 ||| NN
,  ||| S:2054 E:2056 ||| ,
and  ||| S:2056 E:2060 ||| CC
to  ||| S:2060 E:2063 ||| TO
protect  ||| S:2063 E:2071 ||| VB
peri-wound  ||| S:2071 E:2082 ||| JJ
skin ||| S:2082 E:2086 ||| NN
,  ||| S:2086 E:2088 ||| ,
and  ||| S:2088 E:2092 ||| CC
optimise  ||| S:2092 E:2101 ||| JJ
healing ||| S:2101 E:2108 ||| NN
.  ||| S:2108 E:2110 ||| .
Edge  ||| S:2110 E:2115 ||| NN
of  ||| S:2115 E:2118 ||| IN
wound ||| S:2118 E:2123 ||| NN
:  ||| S:2123 E:2125 ||| :
several  ||| S:2125 E:2133 ||| JJ
treatment  ||| S:2133 E:2143 ||| NN
modalities  ||| S:2143 E:2154 ||| NNS
are  ||| S:2154 E:2158 ||| VBP
being  ||| S:2158 E:2164 ||| VBG
investigated  ||| S:2164 E:2177 ||| VBN
and  ||| S:2177 E:2181 ||| CC
introduced  ||| S:2181 E:2192 ||| VBN
to  ||| S:2192 E:2195 ||| TO
improve  ||| S:2195 E:2203 ||| VB
epithelial  ||| S:2203 E:2214 ||| JJ
advancement ||| S:2214 E:2225 ||| NN
,  ||| S:2225 E:2227 ||| ,
which  ||| S:2227 E:2233 ||| WDT
can  ||| S:2233 E:2237 ||| MD
be  ||| S:2237 E:2240 ||| VB
regarded  ||| S:2240 E:2249 ||| VBN
as  ||| S:2249 E:2252 ||| IN
the  ||| S:2252 E:2256 ||| DT
clearest  ||| S:2256 E:2265 ||| JJ
sign  ||| S:2265 E:2270 ||| NN
of  ||| S:2270 E:2273 ||| IN
wound  ||| S:2273 E:2279 ||| JJ
healing ||| S:2279 E:2286 ||| NN
.  ||| S:2286 E:2288 ||| .
The  ||| S:2288 E:2292 ||| DT
TIME  ||| S:2292 E:2297 ||| NNP
principle  ||| S:2297 E:2307 ||| NN
remains  ||| S:2307 E:2315 ||| VBZ
relevant  ||| S:2315 E:2324 ||| JJ
10  ||| S:2324 E:2327 ||| CD
years  ||| S:2327 E:2333 ||| NNS
on ||| S:2333 E:2335 ||| IN
,  ||| S:2335 E:2337 ||| ,
with  ||| S:2337 E:2342 ||| IN
continuing  ||| S:2342 E:2353 ||| VBG
important  ||| S:2353 E:2363 ||| JJ
developments  ||| S:2363 E:2376 ||| NNS
that  ||| S:2376 E:2381 ||| IN
incorporate  ||| S:2381 E:2393 ||| JJ
new  ||| S:2393 E:2397 ||| JJ
evidence  ||| S:2397 E:2406 ||| NN
for  ||| S:2406 E:2410 ||| IN
wound  ||| S:2410 E:2416 ||| JJ
care ||| S:2416 E:2420 ||| NN
.  ||| S:2420 E:2422 ||| .
